TAE Life Sciences to Develop Groundbreaking Therapy for Difficult-to-Treat Cancers, including Head, Neck and GBM; Announces $40 Million Series A Funding

VIEW ARTICLE
If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.